Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

Clindamycin-hameln Solution for Injection 150mg/ml

Approval Number

SIN14599P

Drug Name

Clindamycin-hameln Solution for Injection 150mg/ml

Product Name

Clindamycin-hameln Solution for Injection 150mg/ml

Approval Date

September 3, 2014

Registrant

ZYFAS PHARMA PTE LTD

Licence Holder

ZYFAS PHARMA PTE LTD

Regulatory Information

Registrant

ZYFAS PHARMA PTE LTD

Licence Holder

ZYFAS PHARMA PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

INTRAVENOUS, INTRAMUSCULAR

Medical Information

ATC Code

J01FF01

ATC Item Name

clindamycin

Manufacturer Information

Pharmaceutical Manufacturer

ZYFAS PHARMA PTE. LTD.

Manufacturers

Siegfried Hameln GmbH

Active Ingredients

Ingredient Name

Clindamycin Phosphate 178.23 mg/ml eqv Clindamycin

Strength

150 mg/ml

Drug MonographClindamycin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

Clindamycin-hameln Solution for Injection 150mg/ml - HSA Approval | MedPath